The Joint Corp. (JYNT) vs OnKure Therapeutics, Inc. (OKUR)
A side-by-side comparison of The Joint Corp. and OnKure Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
JYNT
The Joint Corp.
$7.23HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
OKUR
OnKure Therapeutics, Inc.
$2.53HealthcareDelayed quote: Oct 6, 2026, 12:22 PM EDT
Total return — JYNT vs OKUR
growth of $100 · dividends reinvested · last 5yJYNT -84.7% (-31.3%/yr)OKUR -98.2% (-55.5%/yr)JYNT compounded faster over this window
Log scale — wide-divergence pair
JYNT OKUR
JYNT vs OKUR: by the numbers
- •JYNT is the larger company ($103M vs $103M market cap).
- •JYNT is profitable (6.49% net margin) while OKUR runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | JYNT | OKUR |
|---|---|---|
| P/E ratio | 27.27 | N/A |
| Forward P/E | 30.13 | N/A |
| P/S ratio | 1.76 | N/A |
| P/B ratio | 6.50 | 0.60 |
| EV / EBITDA | 26.24 | N/A |
| FCF yield | 4.10% | N/A |
Profitability
| Metric | JYNT | OKUR |
|---|---|---|
| Gross margin | 81.08% | 0.00% |
| Operating margin | 2.45% | 0.00% |
| Net margin | 6.49% | 0.00% |
| ROE | 23.96% | -34.11% |
| ROIC | 5.11% | -35.98% |
Growth (annualized)
| Metric | JYNT | OKUR |
|---|---|---|
| Revenue CAGR (5Y) | -3.57% | N/A |
| EPS CAGR (5Y) | -27.37% | N/A |
| FCF CAGR (5Y) | -16.35% | N/A |
| Total return CAGR (5Y) | -40.34% | -47.19% |
Frequently asked
- Is JYNT or OKUR more profitable?
- JYNT runs the higher net margin — JYNT at 6.49% versus OKUR at 0.00%.
- How have JYNT and OKUR total returns compared?
- Over the past 5 years, JYNT delivered -40.34% and OKUR delivered -47.19% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Joint P/E ratioJoint ROEOnKure Therapeutics ROEJoint operating marginOnKure Therapeutics operating marginJoint revenue growthOnKure Therapeutics revenue growthJoint free cash flowOnKure Therapeutics free cash flow
Joint & OnKure Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.